Peer-reviewed articles

Hanly P, Skally M, Fenlon H, Sharp L. Cost-effectiveness of computed tomography colonography in colorectal cancer screening: a systematic review. Int J Technol Assess Health Care. 2012;28(4):415-423. doi:10.1017/S0266462312000542

ATHENS Group, McSherry LA, Dombrowski SU, et al. ‘It’s a can of worms’: understanding primary care practitioners’ behaviours in relation to HPV using the theoretical domains framework. Implementation Science. 2012;7(1). doi:10.1186/1748-5908-7-73

Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706-1718. doi:10.1093/ije/dys176

Sharp L, Cotton S, Thornton A, et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. Eur J Obstet Gynecol Reprod Biol. 2012;165(2):318-325. doi:10.1016/j.ejogrb.2012.08.001

Donnelly DW, Hegarty A, Sharp L, et al. The Impact of Adjustment for Socioeconomic Status on Comparisons of Cancer Incidence between Two European Countries. Journal of Cancer Epidemiology. 2013;2013:1-6. doi:10.1155/2013/612514

European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51-59. doi:10.1055/s-0032-1325997

Lloyd SM, Stott DJ, de Craen AJM, et al. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS ONE. 2013;8(9):e72642. doi:10.1371/journal.pone.0072642

Sharp L, Tilson L, Whyte S, et al. Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland. BMC Health Serv Res. 2013;13(1):105. doi:10.1186/1472-6963-13-105

Whynes DK, Sharp L, Cotton SC, et al. Impact of alternative management policies on health-related quality of life in women with low-grade abnormal cervical cytology referred for colposcopy. European Journal of Obstetrics Gynecology and Reproductive Biology. 2013;169(1):88-92. doi:10.1016/j.ejogrb.2013.02.006

Timmons A, Gooberman-Hill R, Sharp L. The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public-private healthcare system. Support Care Cancer. 2013;21(1):107-117. doi:10.1007/s00520-012-1498-4

Bennett M, Comber H, Deady S. Incidence of nonmelanoma skin cancer in Ireland. Br J Dermatol. 2013;168(2):452. doi:10.1111/j.1365-2133.2012.11172.x

Hanly P, Walsh PM, O Céilleachair A, et al. Work-related productivity losses in an era of ageing populations: the case of colorectal cancer. J Occup Environ Med. 2013;55(2):128-134. doi:10.1097/JOM.0b013e3182820553

Sharp L, Cotton S, Carsin AE, et al. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psychooncology. 2013;22(2):368-380. doi:10.1002/pon.2097

Maynadie M, De Angelis R, Marcos-Gragera R, et al. Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica. 2013;98(2):230-238. doi:10.3324/haematol.2012.064014

Sharp L, Walsh C, Whyte S, et al. Reply: cost-effectiveness of population-based screening for colorectal cancer. Br J Cancer. 2013;108(5):1211-1212. doi:10.1038/bjc.2012.491

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-1403. doi:10.1016/j.ejca.2012.12.027

McDevitt J, Sharp L, MacDonald D, Dwane F, Comber H. Factors affecting receipt of a medical card in a cohort of colorectal cancer patients, 2002-2006. Ir Med J. 2013;106(4):110-113.

Ó Céilleachair AJ, Hanly P, Skally M, et al. Cost comparisons and methodological heterogeneity in cost-of-illness studies: the example of colorectal cancer. Med Care. 2013;51(4):339-350. doi:10.1097/MLR.0b013e3182726c13

Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013;22(4):745-755. doi:10.1002/pon.3055

Hanly P, Céilleachair AO, Skally M, et al. How much does it cost to care for survivors of colorectal cancer? Caregiver’s time, travel and out-of-pocket costs. Support Care Cancer. Published online May 7, 2013. doi:10.1007/s00520-013-1834-3

Hanly P, Céilleachair AO, Skally M, et al. Time costs associated with informal care for colorectal cancer: an investigation of the impact of alternative valuation methods. Appl Health Econ Health Policy. 2013;11(3):193-203. doi:10.1007/s40258-013-0013-5

Skally M, Hanly P, Sharp L. Cost effectiveness of fecal DNA screening for colorectal cancer: a systematic review and quality appraisal of the literature. Appl Health Econ Health Policy. 2013;11(3):181-192. doi:10.1007/s40258-013-0010-8

Flahavan EM, Sharp L, Bennett K, Barron TI. A cohort study of digoxin exposure and mortality in men with prostate cancer. BJU Int. Published online June 13, 2013. doi:10.1111/bju.12287

Kelly M, Sharp L, Dwane F, Kelleher T, Drummond FJ, Comber H. Factors predicting hospital length-of-stay after radical prostatectomy: a population-based study. BMC Health Serv Res. 2013;13(1):244. doi:10.1186/1472-6963-13-244

de Camargo Cancela M, Comber H, Sharp L. Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study. Br J Cancer. 2013;109(1):272-279. doi:10.1038/bjc.2013.268